{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:55:38Z","timestamp":1793501738119,"version":"4.5.0"},"reference-count":70,"publisher":"Korean College of Neuropsychopharmacology","issue":"1","license":[{"start":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T00:00:00Z","timestamp":1614470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["www.cpn.or.kr"],"crossmark-restriction":true},"short-container-title":["Clin Psychopharmacol Neurosci"],"published-print":{"date-parts":[[2021,2,28]]},"DOI":"10.9758\/cpn.2021.19.1.1","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T09:04:03Z","timestamp":1611824643000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.9758\/crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Drug-induced Hyperthermic Syndromes in Psychiatry"],"prefix":"10.9758","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-4763","authenticated-orcid":false,"given":"Stanley N.","family":"Caroff","sequence":"first","affiliation":[{"name":"Corporal Michael J. Crescenz VA Medical Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"},{"name":"Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA"},{"name":"Malignant Hyperthermia Association of the United States, Sherburne, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1445-1462","authenticated-orcid":false,"given":"Charles B.","family":"Watson","sequence":"additional","affiliation":[{"name":"Malignant Hyperthermia Association of the United States, Sherburne, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-5378","authenticated-orcid":false,"given":"Henry","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Malignant Hyperthermia Association of the United States, Sherburne, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4713","reference":[{"key":"ref1","unstructured":"Knochel JP, Reed G<italic>. Disorders of heat regulation. In: Narins RG, editor. Clinical disorders of fluid and electrolyte metabolism. 5th ed. New York:McGraw-Hill;1994<\/italic>."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(84)90040-8"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2013.07.004"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181dda0d4"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2005.06.002"},{"key":"ref6","unstructured":"Caroff SN<italic>. Hyperthermia associated with other neuropsychiatric drugs. In: Mann SC, Caroff SN, Keck SPEN, Lazarus A, editors. Neuroleptic malignant syndrome and related conditions. 2nd ed. Washington, D.C.:American Psychiatric Publishing, Inc.;2003. p.93-120<\/italic>."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-0059-5"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Meyers EF, Meyers RW<italic>. Thermic stress syndrome. JAMA 1982;247:2098-2099<\/italic>.","DOI":"10.1001\/jama.247.15.2098a"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/conphys\/coz027"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-018-1108-0"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0310-1"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199404000-00008"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(16)30278-4"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.2007.164.6.870"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-020-00767-9"},{"key":"ref16","unstructured":"Caroff SN, Rosenberg H, Mann SC, Campbell EC, Gliatto MF, Sullivan KA<italic>. Neuroleptic malignant syndrome in the perioperative setting. Am J Anesthesiol 2001;28:387-393<\/italic>."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2020.18.2.322"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12222"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2016.0102"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.18120392"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06438"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000640"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S45084"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2014.0047"},{"key":"ref25","unstructured":"Mann SC<italic>. Thermoregulatory mechanisms and antipsychotic drug-related heatstroke. In: Mann SC, Caroff SN, Keck PE Jr., Lazarus A, editors. Neuroleptic Malignant Syndrome and Related Conditions. Second Edition ed. Washington, D.C.:American Psychiatric Publishing, Inc.;2003. p.45-74<\/italic>."},{"key":"ref26","unstructured":"Caroff SN<italic>. Neuroleptic malignant syndrome. In: Mann SC, Caroff SN, Keck PE Jr., Lazarus A, editors. Neuroleptic malignant syndrome and related conditions. 2nd ed. Washington, D.C.:American Psychiatric Publishing, Inc.;2003. p.1-44<\/italic>."},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Huddleston DE, Factor SA<italic>. Parkinsonism-hyperpyrexia syndrome in Parkinson\u2019s disease. In: Frucht SJ, editor. Movement disorder emergencies: diagnosis and treatment. 2nd ed. New York:Humana Press;2013. p.29-42<\/italic>.","DOI":"10.1007\/978-1-60761-835-5_3"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000649"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Kaasinen V, Joutsa J, Noponen T, P\u00e4iv\u00e4rinta M<italic>. Akinetic crisis in Parkinson\u2019s disease is associated with a severe loss of striatal dopamine transporter function: a report of two cases. Case Rep Neurol 2014;6:275-280<\/italic>.","DOI":"10.1159\/000369448"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Fujioka S, Fukae J, Ogura H, Mishima T, Yanamoto S, Higuchi MA, <italic>et al<\/italic><italic>. Hospital-based study on emergency admission of patients with Parkinson\u2019s disease. eNeurologicalSci 2016;4:19-21<\/italic>.","DOI":"10.1016\/j.ensci.2016.04.007"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Alty J, Robson J, Duggan-Carter P, Jamieson S<italic>. What to do when people with Parkinson\u2019s disease cannot take their usual oral medications. Pract Neurol 2016;16:122-128<\/italic>.","DOI":"10.1136\/practneurol-2015-001267"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-7956-4"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-017-0837-9"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.08.010"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000344"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.9758\/cpn.2016.14.4.388"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1177\/1089253220960255"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-020-02990-1"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2017.5144"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092288"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcg109"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1054\/mehy.2000.1047"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.148.6.705"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041867"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12796"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1053\/apmr.2002.32820"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12360"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/0885066612445982"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1017\/s1481803500012598"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2012.07226.x"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Fiege M, Wappler F, Weisshorn R, Gerbershagen MU, Menge M, Schulte Am Esch J<italic>. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d). Anesthesiology 2003;99:1132-1136<\/italic>.","DOI":"10.1097\/00000542-200311000-00020"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1993.tb07526.x"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Baldridge EB, Bessen HA<italic>. Phencyclidine. Emerg Med Clin North Am 1990;8:541-550<\/italic>.","DOI":"10.1016\/S0733-8627(20)30258-3"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90455-8"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.11.1067"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1159\/000166498"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1177\/0269881118793086"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-198611000-00011"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00078"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Katarzyna K, Pawe\u0142 \u015a, Kamilla M<italic>. 25I-NBOME (2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine)-a harmful hallucinogen review. J Anal Toxicol:10. doi: 10.1093\/jat\/bkaa022. [Epub ahead of print]<\/italic>.","DOI":"10.1093\/jat\/bkaa022"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2017_478"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.1998.00209.x"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/emermed-2013-203335"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02675-9"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.03.035"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Van Schoor J, Khanderia E, Thorniley A<italic>. Dantrolene is not the answer to 2,4-dinitrophenol poisoning: more heated debate. BMJ Case Rep 2018;11:e225323<\/italic>.","DOI":"10.1136\/bcr-2018-225323"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199203000-00023"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.135.9.1097"},{"key":"ref69","unstructured":"Shader RI, Greenblatt DJ<italic>. Uses and toxicity of belladonna alkaloids and synthetic anticholinergics. Semin Psychiatry 1971;3:449-476<\/italic>."},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ, Shader RI<italic>. Drug therapy. Anticholinergics. N Engl J Med 1973;288:1215-1219<\/italic>.","DOI":"10.1056\/NEJM197306072882306"}],"container-title":["Clinical Psychopharmacology and Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-01-01.pdf","content-type":"unspecified","content-version":"tdm","intended-application":"text-mining"},{"URL":"http:\/\/pdf.medrang.co.kr\/CPN2\/2021\/019\/cpn019-01-01.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T05:37:36Z","timestamp":1723009056000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.1.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,28]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2,28]]}},"alternative-id":["10.9758\/cpn.2021.19.1.1"],"URL":"https:\/\/doi.org\/10.9758\/cpn.2021.19.1.1","relation":{},"ISSN":["1738-1088","2093-4327"],"issn-type":[{"value":"1738-1088","type":"print"},{"value":"2093-4327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,28]]},"assertion":[{"value":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.1.1","URL":"http:\/\/www.cpn.or.kr\/journal\/view.html?doi=10.9758\/cpn.2021.19.1.1","name":"the_journal","label":"Clinical Psychopharmacology and Neuroscience","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"2020-10-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2021 The","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"name":"license","label":"License","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}